# Sunshine Biopharma Inc.

Sunshine Biopharma Inc. is a public company listed on Nasdaq as SBFM, headquartered in Fort Lauderdale, FL, United States.

## Company overview

- **Legal name:** Sunshine Biopharma Inc.
- **Former names in filing history:** Sunshine Biopharma, Inc (2009-11-06 to 2024-10-17); Mountain West Business Solutions, Inc (2007-11-05 to 2009-11-02); mountain west business solutions,inc (2007-10-19 to 2007-10-19); mountain state business solutions,inc (2007-05-25 to 2007-05-25)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Fort Lauderdale, FL, United States
- **Incorporated in:** CO
- **Fiscal year end:** December 31
- **Tickers:** Nasdaq: SBFM, Nasdaq: SBFMW
- **SEC CIK:** 0001402328

## About

Sunshine Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001402328, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-04-03, it reported annual revenue of USD 36,305,891; net income of USD -5,975,352; total assets of USD 30,079,167 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $36.3M (USD 36,305,891)
- **Net income:** -$6.0M (USD -5,975,352)
- **Total assets:** $30.1M (USD 30,079,167)
- **Operating cash flow:** -$5.3M (USD -5,331,073)

### FY2024 (period ended 2024-12-31)

- **Revenue:** $34.9M (USD 34,874,283)
- **Net income:** -$5.1M (USD -5,134,116)
- **Total assets:** $30.6M (USD 30,560,392)
- **Operating cash flow:** -$12.5M (USD -12,531,180)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $24.1M (USD 24,092,787)
- **Net income:** -$4.5M (USD -4,506,044)
- **Total assets:** $27.3M (USD 27,346,961)
- **Operating cash flow:** -$8.8M (USD -8,775,111)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $4.3M (USD 4,345,603)
- **Net income:** -$26.7M (USD -26,744,440)
- **Total assets:** $29.2M (USD 29,243,848)
- **Cash and equivalents:** $21.8M (USD 21,826,437)
- **Operating cash flow:** -$5.2M (USD -5,248,358)

## Recent SEC filings

- Form 8-K — filed 2026-10-09 — period 2026-10-08 — CURRENT REPORT
- Form 424B4 — filed 2026-10-09 — PROSPECTUS
- Form S-1 — filed 2026-10-02 — FORM S-1
- Form 8-K — filed 2026-09-16 — period 2026-09-15 — FORM 8-K
- Form 8-K — filed 2026-09-11 — period 2026-09-11 — FORM 8-K
- Form S-1 — filed 2026-08-28 — FORM S-1
- Form 8-K — filed 2026-08-28 — period 2026-08-25 — CURRENT REPORT
- Form 10-Q — filed 2026-08-13 — period 2026-06-30 — FORM 10-Q FOR JUN 2026
- Form 8-K — filed 2026-08-03 — period 2026-08-03 — FORM 8-K
- Form 8-K — filed 2026-07-20 — period 2026-07-20 — FORM 8-K
- Form 8-K — filed 2026-07-10 — period 2026-07-08 — CURRENT REPORT
- Form 8-K — filed 2026-05-29 — period 2026-05-28 — CURRENT REPORT

---

Updated: 2026-10-23T06:09:42Z

Canonical page: https://altss.com/profile/sunshine-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology